We present a prospective study (1984)(1985)(1986)(1987)(1988)(1989)(1990)(1991)(1992) of the various biochemical indices used to detect phaeochromocytoma. Selective methods entailing high performance liquid chromatography were used throughout the study. Results of catecholamines were compared with HMMA, NMT and metadrenaline values in the initial 24 hour urine samples from 31 patients with histologically confirmed phaeochromocytoma.
Patients in whom the diagnosis of phaeochromocytoma was subsequently excluded (n = 50) were initially investigated to rule out the diagnosis or were referred from other hospitals because of equivocal biochemical results.
Urine samples (24 hour) were collected into bottles containing 15 ml of 6M hydrochloric acid as a preservative. Urine specimens from outpatients were collected in the presence of metabisulphite7 and were acidified with 6M hydrochloric acid on receipt at the laboratory. All urine samples were stored at -15°C before assay. Uniform chromatographic conditions using reverse phase ion-pair chromatography were used for all measurements.4 Urinary concentrations of noradrenaline and adrenaline, dopamine (DA), HMMA and acid-hydrolysed normetadrenaline and metadrenaline were measured by high performance liquid chromatography (HPLC) with electrochemical detection.4 89 An electrode potential of 065 volts for catecholamine measurements and 0-75 volts for all other measurements against an Ag/AgCl reference electrode was established from hydrodynamic voltammograms. 4 Reference ranges were derived from the analysis of 24 hour urine samples from normotensive (n = 18) and essential hypertensive patients (n = 56) without phaeochromocytoma. Data were normally distributed for HMMA, normetadrenaline, metadrenaline and combined normetadrenaline and metadrenaline (combined metadrenalines). The distributions for noradrenaline, adrenaline, dopamine and combined noradrenaline and adrenaline (combined catecholamines) were very skewed and were normalised by log-transformation. A value was defined as raised if greater than the upper reference limit: this was taken to be two standard deviations above the mean of the reference population.
Results
The figure shows the urinary excretion of catecholamines Results shown as median and range (in parentheses). adrenaline or normetadrenaline. Table 2 shows the results of urinary catecholamines and metabolites in both the phaeochromocytoma and non-phaeochromocytoma groups of patients. On the basis of these data, sensitivity, specificity, and predictive values were calculated using standard formulae.'0 The overall sensitivity of normetadrenaline was 97%, the specificity 58%, and the predictive value of a positive test 59% (table 3) . Combined metadrenalines had a similar sensitivity but improved specificity (86%) and positive predictive value (81%).
Use of a combined catecholamine value increased the sensitivity of individual noradrenaline and adrenaline values from 90% and 58% to a value of 97% while the positive predictive value did not change (68% Our devised strategy involves the initial assessment of urinary noradrenaline and adrenaline values. Urinary catecholamines provided a similar diagnostic sensitivity to the more costly and technically demanding measurement of normetadrenaline and metadrenaline excretion. Increased excretion of noradrenaline, adrenaline, or combined catecholamines was found in all 31 patients with phaeochromocytoma. The measurement of combined metadrenalines with higher specificity is used in all patients with a strong clinical suspicion of phaeochromocytoma, in patients with a borderline increase in catecholamines, and as a confirmatory procedure in patients with raised catecholamine values. Our findings of three patients with raised adrenaline but normal noradrenaline secretion agree with the report of Smythe et al and further confirm the advantages of measuring individual catecholamines."2 Both normetadrenaline and metadrenaline excretion were also increased in two of these three patients. An increased adrenaline excretion was found as the sole individual biochemical abnormality in one patient (case 6).
Our data highlight the limitations of HMMA in the biochemical detection of phaeochromocytoma, in spite of the use of a highly selective procedure. HMMA failed to indicate the presence of a phaeochromocytoma in the initial urine samples in six out of the 31 patients and is similar to the experience of previous studies using less specific spectrophotometric methods."-'5 Even with an improved analytical method, HMMA pro-vided a significantly lower sensitivity (81%) than either measurement of the combined catecholamines (97%) or combined metadrenalines (97%). This raises doubts regarding measurement of HMMA as the only biochemical index to indicate the presence of a phaeochromocytoma. 
